drugset / Trial / NCT01061866
Thalidomide Low Threshold in Epilepsy
Phase 1/2
Completed
7 enrolled
National Institute of Neurology and Neurosurgery, Mexico
National Council of Science and Technology, Mexico · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether thalidomide is effective in the refractory epilepsy treatment.
Timeline
- Start
- 2006-06
- Primary completion
- 2007-06
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | 200 mg | — |